Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies.
Journal: Lancet (London, England)
Published: March 21, 2025
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
Journal: JAMA cardiology
Published: April 06, 2022
Constitutively Activating GNAS Somatic Mutation in Right Ventricular Outflow Tract Tachycardia.
Journal: Circulation. Arrhythmia and electrophysiology
Published: September 30, 2021
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 06, 2021
Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double-blind, phase 2 trial.
Journal: Diabetes, obesity & metabolism
Published: April 19, 2021
A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism-A Proof-of-Concept Trial.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 02, 2019
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease.
Journal: Vascular medicine (London, England)
Published: July 07, 2019
Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.
Journal: Journal of the American College of Cardiology
Published: January 27, 2016
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry.
Journal: Journal of the American College of Cardiology
Published: December 21, 2015
Tbx5 is required for avian and Mammalian epicardial formation and coronary vasculogenesis.
Journal: Circulation research
Published: September 24, 2014
Last Updated: 09/26/2026